// App-Quantinova.ai

: SAT-183 Activating Transcription Factor 4 (ATF4) As A Possible Mediator Of Gluconeogenic And Lipogenic Actions Of Fat Mass And Obesity Associated (FTO) In Liver

Researchers

Presenter

  • Tooru Mizuno

Principal Investigators

  • Pei San Lew

Medical Centers

  • Univ of Manitoba, Winnipeg, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Fatty Liver Disease

  • Type 2 diabetes mellitus

  • Hyperglycemia

  • Diabetes

  • Obesity

Biomarkers

  • Stearoyl-CoA desaturase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved